I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
A Prelude to Human Growth Hormones
Recombinant Human Growth Hormones
Evolution of Recombinant Human Growth Hormones (hGH)
COVID-19 Impact on Human Growth Hormone Drugs
GLOBAL MARKET OVERVIEW
Global Human Growth Hormone Drugs Market to Witness Steady Growth
List of Select Approved Prescription Daily-dose hGH Products by
Indication
List of Select Approved Prescription Weekly-dose hGH Products
by Indication
Subcutaneous Route Dominates Human Growth Hormone Drugs Market
Growth Hormone Deficiency Application Leads the Human Growth
Hormone Drugs Market
North America and Europe Dominate, Asia-Pacific to Witness
Fastest Growth
Market Restraints
Competition
EXHIBIT 1: Leading Global Recombinant hGH Products Market:
(2020): Annual Sales in US$ Million for Norditropin,
Genotropin, Humatrope, Nutropin, Saizen, EGRIFTA
EXHIBIT 2: Global Recombinant hGH Products Market (2020):
Market Share of Leading Players
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
High Prevalence of Growth Hormone Deficiency Disorders
Pediatric GHD Rules, while Adult GHD Remains Underserved
EXHIBIT 3: Worldwide Recombinant Human Growth Hormone Market by
Indication (2020): Percentage Breakdown of Value Sales for
Pediatric GHD; Adult GHD, Turner Syndrome & Idiopathic Short
Stature; and Others
Long-Acting hGH Drugs - A Game Changer for the Human Growth
Hormone Drugs Market
Approval of Novo Nordisk?s Once-Weekly Sogroya to Transform the
Market Landscape
Other Noteworthy Developments in the Long Acting hGH Space
Patent Expiry Paves Way for the Emergence of Biosimilars
Strong Innovation Drive Takes Hold of the hGH Industry
Manufacturers Bet on Novel Drug Delivery Technologies
Non-Prescription/Off-Label Usage - A Concern
Needle-less Drug Delivery Systems to Wipe Out of Syringes
Drug Delivery Device Options for Marketed hGH Products
Major Growth Restraining Factors
Complex Delivery System
High Cost of hGH Treatment
Biosimilars Threaten Revenue Growth Erosion
PIPELINE ANALYSIS
Select Daily and Long-Acting Human Growth Hormone Products List
in Phase III Pipeline

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Human Growth
Hormone Drugs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Human Growth Hormone Drugs
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Human Growth Hormone
Drugs by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027

Table 4: World Current & Future Analysis for Subcutaneous by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Subcutaneous by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Subcutaneous by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Current & Future Analysis for Intramuscular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Intramuscular by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Intramuscular by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Current & Future Analysis for Intravenous by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Intravenous by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Intravenous by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Current & Future Analysis for Oral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 16: World Current & Future Analysis for Hospital Pharmacy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospital Pharmacy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Hospital Pharmacy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Current & Future Analysis for Specialty
Pharmacy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Specialty Pharmacy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Specialty Pharmacy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Current & Future Analysis for Retail Pharmacy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Retail Pharmacy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Retail Pharmacy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Current & Future Analysis for Online Pharmacy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Online Pharmacy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Online Pharmacy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Current & Future Analysis for Growth Hormone
Deficiency by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Growth Hormone Deficiency
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Growth Hormone
Deficiency by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 31: World Current & Future Analysis for Turner Syndrome
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Turner Syndrome by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Turner Syndrome by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 34: World Current & Future Analysis for Idiopathic Short
Stature (ISS) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Idiopathic Short Stature
(ISS) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Idiopathic Short
Stature (ISS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 37: World Current & Future Analysis for Prader-Willi
Syndrome (PWS) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 38: World Historic Review for Prader-Willi Syndrome (PWS)
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Prader-Willi Syndrome
(PWS) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 40: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 41: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 43: USA Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: USA Historic Review for Human Growth Hormone Drugs by
Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 46: USA Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Human Growth Hormone Drugs by
Distribution Channel - Hospital Pharmacy, Specialty Pharmacy,
Retail Pharmacy and Online Pharmacy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 48: USA 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 49: USA Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: USA Historic Review for Human Growth Hormone Drugs by
Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: USA 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

CANADA
Table 52: Canada Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Canada Historic Review for Human Growth Hormone Drugs
by Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 55: Canada Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Human Growth Hormone Drugs
by Distribution Channel - Hospital Pharmacy, Specialty
Pharmacy, Retail Pharmacy and Online Pharmacy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Canada 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 58: Canada Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Canada Historic Review for Human Growth Hormone Drugs
by Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

JAPAN
Table 61: Japan Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: Japan Historic Review for Human Growth Hormone Drugs
by Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 64: Japan Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Japan Historic Review for Human Growth Hormone Drugs
by Distribution Channel - Hospital Pharmacy, Specialty
Pharmacy, Retail Pharmacy and Online Pharmacy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: Japan 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 67: Japan Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Japan Historic Review for Human Growth Hormone Drugs
by Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Japan 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

CHINA
Table 70: China Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: China Historic Review for Human Growth Hormone Drugs
by Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: China 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 73: China Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: China Historic Review for Human Growth Hormone Drugs
by Distribution Channel - Hospital Pharmacy, Specialty
Pharmacy, Retail Pharmacy and Online Pharmacy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: China 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 76: China Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: China Historic Review for Human Growth Hormone Drugs
by Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: China 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

EUROPE
Table 79: Europe Current & Future Analysis for Human Growth
Hormone Drugs by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 80: Europe Historic Review for Human Growth Hormone Drugs
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 81: Europe 15-Year Perspective for Human Growth Hormone
Drugs by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027

Table 82: Europe Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: Europe Historic Review for Human Growth Hormone Drugs
by Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 85: Europe Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Human Growth Hormone Drugs
by Distribution Channel - Hospital Pharmacy, Specialty
Pharmacy, Retail Pharmacy and Online Pharmacy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: Europe 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 88: Europe Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: Europe Historic Review for Human Growth Hormone Drugs
by Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

FRANCE
Table 91: France Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: France Historic Review for Human Growth Hormone Drugs
by Route Of Administration - Subcutaneous, Intramuscular,
Intravenous and Oral Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: France 15-Year Perspective for Human Growth Hormone
Drugs by Route Of Administration - Percentage Breakdown of
Value Sales for Subcutaneous, Intramuscular, Intravenous and
Oral for the Years 2012, 2021 & 2027

Table 94: France Current & Future Analysis for Human Growth
Hormone Drugs by Distribution Channel - Hospital Pharmacy,
Specialty Pharmacy, Retail Pharmacy and Online Pharmacy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: France Historic Review for Human Growth Hormone Drugs
by Distribution Channel - Hospital Pharmacy, Specialty
Pharmacy, Retail Pharmacy and Online Pharmacy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: France 15-Year Perspective for Human Growth Hormone
Drugs by Distribution Channel - Percentage Breakdown of Value
Sales for Hospital Pharmacy, Specialty Pharmacy, Retail
Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027

Table 97: France Current & Future Analysis for Human Growth
Hormone Drugs by Application - Growth Hormone Deficiency,
Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi
Syndrome (PWS) and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: France Historic Review for Human Growth Hormone Drugs
by Application - Growth Hormone Deficiency, Turner Syndrome,
Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: France 15-Year Perspective for Human Growth Hormone
Drugs by Application - Percentage Breakdown of Value Sales for
Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short
Stature (ISS), Prader-Willi Syndrome (PWS) and Other
Applications for the Years 2012, 2021 & 2027

GERMANY
Table 100: Germany Current & Future Analysis for Human Growth
Hormone Drugs by Route Of Administration - Subcutaneous,
Intramuscular, Intravenous and Oral - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Germany Historic Review for Human Growth Hormone

Please contact our Customer Support Center to get the complete Table of Contents